Monsoon AU CAR-T Showcase

Arovella CEO, Dr Michael Baker, spoke at the Sydney AU CAR-T Showcase in November, hosted by Monsoon Communications.

Arovella is advancing next-gen CAR-iNKT therapies designed to go beyond the limits of CAR-T—targeting blood cancers and solid tumours.

View presentation

Previous
Previous

Arovella Newsletter November 2025

Next
Next

Investor Presentation